Vol.

No.

February 14, 2025Feb 14, 2025

DOWNLOAD THE PDF

On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty

Cover Story

Black History Month Free Podcast The Directors

On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers

The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty

By Paul Goldberg

Is the Community Outreach and Engagement mandate the next item on the chopping block as the Trump administration makes its mark on science policy? What about health disparities research?

White House

Federal judge blocks Trump administration’s move to limit indirect costs to 15% for NIH-funded institutions
The move could gut academic cancer research

By Paul Goldberg

Free Guest Editorial

Preparing to take care of each other in ways we never imagined

By W. Kimryn Rathmell

Guest Editorial

From the chairs of ECOG-ACRIN: A perspective on indirect costs

By Peter J. O'Dwyer and Mitchell D. Schnall

White House

RFK Jr. is confirmed, NCORP stops collecting data on sexual orientation, gender
One month in: Trump’s impact on oncology

By Claire Marie Porter and Jacquelyn Cobb

Cancer History Project Free Podcast

20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect

By Yiqing Wang

The War on Cancer: After half a century of progress, a promising prognosis may be Richard Nixon’s greatest legacy

By Jim Byron

Podcasts

In The Headlines: Kimryn Rathmell on loss and caring for our community in uncertain times

In Brief

Aleksandar Sekulic named physician-in-chief at TGen

Boris Naraev joins TGH Cancer Institute, USF Health

Daniel Nomura named editor-in-chief of Molecular Cancer Therapeutics

Case CCC earns NCI merit award

Children’s National Hospital, Virginia Tech expand partnership for pediatric cancer research

Funding Opportunities

The Stephenson Global Pancreatic Cancer Research Institute creates Global Scientific Awards to advance pancreatic cancer research

Clinical Roundup

Talzenna + Xtandi improve OS in metastatic castration-resistant prostate cancer, phase III study finds

Chemo + immunotherapy may improve bladder preservation, interim data from phase II study show

Pain linked to increased tobacco and cannabis use among cancer survivors, study finds

Researchers identify gut bacteria as key to ovarian cancer immunotherapy resistance

Cortechs.ai, EDAP TMS announce OnQ prostate-assisted robotic HIFU procedure

Drugs & Targets

FDA approves Adcetris + lenalidomide + rituximab for r/r large B-cell lymphoma

FDA approves Gomekli for pediatric patients with neurofiromatosis type 1

EC grants marketing authorization for Removab as a treatment for malignant ascites

Moffitt, 1ST Biotherapeutics collaborate to advance immuno-oncology

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues